Home
Contact Us
Aggregated China Business Blogs
2021-02-06
Jingxin Pharmaceutical's 500 million yuan fixed increase is approved to issue fair value to help increase net profit over 100 million yuan-Finance-
Aggregated Source:
Caishen.Co
Caishen.Co delivers
Primary Data for China`s Secondary Investment and Stock Markets
. Full details at
Caishen.Co
.
Original URL:
Click here to visit original article
Copyright
Caishen.Co
Related Posts
Vietnam wins on China’s value-chain rise
Principal Financial Group Inc. Increases Stock Position in Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) Dakota Financial News
Yellen: Indo-Pacific trade talks need ‘further work’
DealShot: 16 Deals Surpassing $180 Million With SDIC Venture Capital, SBCVC And Many Others
E-Shang Redwood Scores $100M From Azerbaijan Fund For Japan Projects
China Mobile Looks To The Cloud In New Search Engine Deal
Orchid Asia Joins Series B Round In China’s Weimeizi
China plans to quadruple nuclear weapons stockpile, Pentagon says
Bond investors start to ask questions about Chinese takeovers
Xu Zhiyong, Chinese civil rights activist
SEARCH
Browse News
February 2021
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
« Jan
Mar »
Useful Sites
China Media Blog
China Legal Blog
China Travel Blog
Caishen.Co
ChinaPulse.com
ZhongjintouX.com